Respiratory

Encorium has performed 16 studies in the respiratory area involving over 5000 patients at 150 international sites. We have conducted Phase I-IV studies in asthma with 10-500+ patients and have an experienced team with extensive operational experience in both adult and pediatric asthma trials. Drug classes include inhaled glucocorticosteroid or B2 agonist, Anti IgE, protein peptides, medical device (delivery system) GCRP IA&IB

In addition, we have conducted 5 studies in COPD and smoking cessation, the latter involving over 2000 subjects.